Nostrand Robert L. Van

Companies

• Galena BiopharmaBoard member Dec 29, 2017 to now¹
• Intra-Cellular Therapies, Inc.Board member Jan 14, 2014 to Apr 2, 2025²
• Yield10 BioscienceBoard member Nov 9, 2006 to Apr 1, 2024³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• Galena Biopharma SLS82,900 shares⁴$881.0K at $10.63Jan 7, 2026
• YBYield10 Bioscience YTEN48,635 shares⁵Mar 28, 2024
• ICIntra-Cellular Therapies, Inc.0 shares⁶Apr 2, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

• Jan 7, 2026Granted 50,000 shares of Galena Biopharma⁴
• Jun 12, 2025Bought 10,000 shares at $1.48 of Galena Biopharma⁷
• Apr 2, 2025Returned to company 11,340 shares at $132.00 of Intra-Cellular Therapies, Inc.⁶
• Jan 10, 2025Granted 12,500 shares of Galena Biopharma⁸
• Jun 28, 2024Granted 83 shares at $68.49 of Intra-Cellular Therapies, Inc.⁹
• Jun 23, 2024Exercised options 1,567 shares of Intra-Cellular Therapies, Inc.¹⁰
• Jun 18, 2024Sold 11,109 shares at $76.07 of Intra-Cellular Therapies, Inc.¹¹
• Jun 18, 2024Sold 8,891 shares at $75.71 of Intra-Cellular Therapies, Inc.¹¹
• Jun 18, 2024Exercised options 20,000 shares at $16.86 of Intra-Cellular Therapies, Inc.¹¹
• Mar 31, 2024Granted 79 shares at $69.20 of Intra-Cellular Therapies, Inc.¹²
• Mar 28, 2024Granted 11,924 shares of Yield10 Bioscience⁵
• Feb 27, 2024Sold 10,349 shares at $73.14 of Intra-Cellular Therapies, Inc.¹³
• Feb 27, 2024Sold 9,651 shares at $72.71 of Intra-Cellular Therapies, Inc.¹³
• Feb 27, 2024Exercised options 20,000 shares at $18.56 of Intra-Cellular Therapies, Inc.¹³
• Jan 22, 2024Granted 6,000 shares of Galena Biopharma¹⁴
• Dec 31, 2023Granted 76 shares at $71.62 of Intra-Cellular Therapies, Inc.¹⁵
• Dec 29, 2023Granted 18,879 shares of Yield10 Bioscience¹⁶
• Sep 30, 2023Granted 105 shares at $52.09 of Intra-Cellular Therapies, Inc.¹⁷
• Sep 29, 2023Granted 13,868 shares of Yield10 Bioscience¹⁸
• Jun 30, 2023Granted 2,040 shares of Yield10 Bioscience¹⁹
• Jun 30, 2023Granted 85 shares at $63.32 of Intra-Cellular Therapies, Inc.²⁰
• Apr 17, 2023Sold 10,000 shares at $63.00 of Intra-Cellular Therapies, Inc.²¹
• Apr 17, 2023Exercised options 10,000 shares at $13.05 of Intra-Cellular Therapies, Inc.²¹
• Mar 31, 2023Granted 1,642 shares of Yield10 Bioscience²²
• Mar 31, 2023Granted 95 shares at $54.15 of Intra-Cellular Therapies, Inc.²³